Cell death–mediated cytokine release and its therapeutic implications
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Targeting apoptosis to treat diseases has seen tremendous success over the past decades. More recently, alternative forms of regulated cell death, including pyroptosis and necroptosis, have been described. Understanding the molecular cascades regulating both pyroptosis and necroptosis will yield even more targets to treat diseases. These lytic forms of cell death are distinct from apoptosis due to their characteristic lysis and release of cellular components that promote disease or direct a beneficial immune response. In this review, we focus on how pyroptosis and necroptosis, which release potent immune cytokines such as IL-1 and IL-18, contribute to various diseases. We also consider the important role that the executioners of these cell death pathways, GSDMD and MLKL, play in the progression of inflammatory diseases. Crosstalk between the different cell death pathways likely plays a major role physiologically. New therapeutic strategies targeting these specific molecules hold enormous potential for managing inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Kayagaki, N., Stowe, I. B., Lee, B. L., O’Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q. T., et al. (2015) · Nature · doi:10.1038/nature15541 · Cited by 3,686 · cited 1×
“Regulated cell death has been understood as a concept for decades, with apoptosis being the first well-defined process in which cells dismantle themselves in a process that is generally immunologically quiet (Kerr et al., 1972; Elmore, 2007).”
BackgroundChemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · cited 1×
“IL-1β (canakinumab) IL-1 decoy receptor (rilonacept) de Koning et al., 2015 AOSD IL-1β IL-18?”
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Pore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771 · cited 3×
“…and disease https://doi.org/10.1084/jem.20181892 D ow nloaded from https://rupress.org/jem /article-pdf/216/7/1474/761441/jem _20181892.pdf" /><m eta nam e="dc.identifier" content="10.1084/jem .20181892 by guest on 10 February 2020 also regulate necroptosis (Elmore, 2007; Gurung et al., 2014).”
BackgroundInfluentialMechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759 · cited 1×
“A single specific trigger for NLRP3 activation is not known, but many cellular insults induce NLRP3 inflammasome activation and cleavage of caspase-1, including loss of cellular ion homeostasis and plasma membrane disruption (Kanneganti et al., 2006; He et al., 2016; Jo et al., 2016).”
BackgroundMixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.-H., Zhong, C.-Q., & Han, J. (2015) · Cell Research · doi:10.1038/cr.2015.139 · Cited by 2,517
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435 · cited 1×
“In cells where caspase-8 is inhibited or missing, inflammatory signaling via TNF superfamily receptors, IFNs, TLR3, or TLR4 can lead to the phosphorylation of RIPK1, RIPK3, and ultimately mixed-lineage kinase domain-like pseudokinase (MLKL; Fig. 2; Holler et al., 2000; Cho et al., 2009; He et al., 2009; Linkermann and…”
BackgroundReceptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009) · Cell · doi:10.1016/j.cell.2009.05.021 · Cited by 2,214 · cited 1×
“2; Holler et al., 2000; Cho et al., 2009; He et al., 2009; Linkermann and Green, 2014; Wang et al., 2014; Mocarski et al., 2015).”
Necroptosis and its role in inflammation
Pasparakis, M., & Vandenabeele, P. (2015) · Nature · doi:10.1038/nature14191 · Cited by 2,148 · cited 3×
“Necroptosis is also generally considered a backup form of cell death when parts of the apoptotic pathway are inhibited by pathogens or inhibitors (Pasparakis and Vandenabeele, 2015).”
BackgroundAIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., & Alnemri, E. S. (2009) · Nature · doi:10.1038/nature07710 · Cited by 1,831 · cited 1×
“…e="dc.identifier" content="10.1084/jem .20181892 by guest on 10 February 2020 need processing by caspase-1, such as IL-1α, IL-33, HMGB1, ATP, and ASC complexes, are released, further contributing to the inflammatory response (Vande Walle et al., 2011; Basiorka et al., 2018; Frank and Vince, 2019).”
BackgroundInfluentialMolecular mechanisms regulating NLRP3 inflammasome activation
Jo, E.-K., Kim, J. K., Shin, D.-M., & Sasakawa, C. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.95 · Cited by 1,378
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32247-x · Cited by 1,344
Linkermann, A., & Green, D. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1310050 · Cited by 1,103 · cited 2×
“In cells where caspase-8 is inhibited or missing, inflammatory signaling via TNF superfamily receptors, IFNs, TLR3, or TLR4 can lead to the phosphorylation of RIPK1, RIPK3, and ultimately mixed-lineage kinase domain-like pseudokinase (MLKL; Fig. 2; Holler et al., 2000; Cho et al., 2009; He et al., 2009; Linkermann and…”
BackgroundMethodPyroptosis versus necroptosis: similarities, differences, and crosstalk
Frank, D., & Vince, J. E. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0212-6 · Cited by 1,062
Necroptosis in development, inflammation and disease
Weinlich, R., Oberst, A., Beere, H. M., & Green, D. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.149 · Cited by 1,016
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., et al. (2017) · Nature · doi:10.1038/nature25158 · Cited by 983
Linear ubiquitination prevents inflammation and regulates immune signalling
Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W.-L., et al. (2011) · Nature · doi:10.1038/nature09816 · Cited by 940 · cited 1×
“…cell apoptosis and inflammation that is promoted by RIPK1, RIPK3, MLKL, caspase-1/11, NLRP3, and IL-1β, suggesting that inhibition of cell death in this model may protect from similar skin disorders in humans (Gijbels et al., 1996; Kumari et al., 2014; Rickard et al., 2014; Gurung et al., 2016b).”
BackgroundInterleukin-18 and IL-18 Binding Protein
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00289 · Cited by 938 · cited 1×
“…the autoinhibitory C-terminal domain of GSDMD is released from the pore-forming N-terminal domain, leading to insertion of the GSDMD N-terminal domain into the plasma membrane and oligomerization with other GSDMD fragments, thereby generating a large pore 10–20 nm in diameter (Ding et al., 2016).”
BackgroundUse of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner, J. B., Leslie, K. S., Hachulla, E., Quartier, P., Gitton, X., Widmer, A., Patel, N., & Hawkins, P. N. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810787 · Cited by 869 · cited 2×
“IL-18 is also thought to contribute to the pathogenesis of a number of skin diseases, including psoriasis, atopic dermatitis, and lupus, but more definitive studies are needed to determine whether inhibition with IL-18 binding protein (IL-18BP) will be beneficial (Lee et al., 2015).”
BackgroundKuriakose, T., Man, S. M., Subbarao Malireddi, R. K., Karki, R., Kesavardhana, S., Place, D. E., Neale, G., Vogel, P., & Kanneganti, T.-D. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag2045 · Cited by 818 · cited 2×
“pyroptosis with potential to regulate cell death during other currently unknown diseases (Kuriakose et al., 2016; Koehler et al., 2017; Maelfait et al., 2017; Guo et al., 2018).”
BackgroundSelf-citationESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences
Gong, Y.-N., Guy, C., Olauson, H., Becker, J. U., Yang, M., Fitzgerald, P., Linkermann, A., & Green, D. R. (2017) · Cell · doi:10.1016/j.cell.2017.03.020 · Cited by 689
Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner
Conos, S. A., Chen, K. W., De Nardo, D., Hara, H., Whitehead, L., Núñez, G., Masters, S. L., Murphy, J. M., Schroder, K., Vaux, D. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613305114 · Cited by 485
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Xu, D., Jin, T., Zhu, H., Chen, H., Ofengeim, D., Zou, C., Mifflin, L., Pan, L., Amin, P., Li, W., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.041 · Cited by 461 · cited 18×
“In physiological conditions, it is not surprising that RIPK1- and RIPK3-mediated expression of inflammatory cytokines or induction of necroptosis indirectly promote further downstream apoptosis, necroptosis, or pyroptosis in other nearby cells.”
BackgroundInfluentialZaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M., & Kanneganti, T.-D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002046 · Cited by 411 · cited 1×
“Blockade of IL-18 may be beneficial in the context of colitis, inflammatory bowel disease, or cardiac disease, but conflicting findings on harmful and beneficial roles for IL-18 require more study (Zaki et al., 2010; Dinarello et al., 2013; Kanai et al., 2013; Toldo et al., 2014).”
BackgroundSelf-citationMan, S. M., Karki, R., Malireddi, R. K. S., Neale, G., Vogel, P., Yamamoto, M., Lamkanfi, M., & Kanneganti, T.-D. (2015) · Nature Immunology · doi:10.1038/ni.3118 · Cited by 380
Self-citationAbsence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury
Roychowdhury, S., McMullen, M. R., Pisano, S. G., Liu, X., & Nagy, L. E. (2013) · Hepatology · doi:10.1002/hep.26200 · Cited by 304
Karki, R., Man, S. M., Malireddi, R. K. S., Gurung, P., Vogel, P., Lamkanfi, M., & Kanneganti, T.-D. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.006 · Cited by 272
Self-citationSensing of viral and endogenous RNA by ZBP1/DAI induces necroptosis
Maelfait, J., Liverpool, L., Bridgeman, A., Ragan, K. B., Upton, J. W., & Rehwinkel, J. (2017) · The EMBO Journal · doi:10.15252/embj.201796476 · Cited by 237 · cited 1×
“pyroptosis with potential to regulate cell death during other currently unknown diseases (Kuriakose et al., 2016; Koehler et al., 2017; Maelfait et al., 2017; Guo et al., 2018).”
Background
Cited by
Molecular mechanisms of cell death in neurological diseases
Moujalled, D., Strasser, A., & Liddell, J. R. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00814-y · Cited by 749
“respectively, may allow improved outcomes for patients with these diseases [142].”
BackgroundLiu, Z., Yao, X., Jiang, W., Li, W., Zhu, S., Liao, C., Zou, L., Ding, R., & Chen, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01751-2 · Cited by 430
PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality
Pandian, N., & Kanneganti, T.-D. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200508 · Cited by 285
Self-citationBanoth, B., Tuladhar, S., Karki, R., Sharma, B. R., Briard, B., Kesavardhana, S., Burton, A., & Kanneganti, T.-D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015924 · Cited by 237
Self-citationKahn, D., Macias, E., Zarini, S., Garfield, A., Zemski Berry, K., MacLean, P., Gerszten, R. E., Libby, A., Solt, C., Schoen, J., et al. (2022) · Endocrinology · doi:10.1210/endocr/bqac140 · Cited by 97
Metadata
- Authors
- Place, D. E., & Kanneganti, T.-D.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2019-06-11
- Volume
- 216
- Issue
- 7
- Pages
- 1474-1486
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2949691727
- Cited by
- 84
- References
- 30
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.